Preliminary safety results of an Italian early-access program (EAP) with cabazitaxel plus prednisone (CbzP) in patients with docetaxel-refractory metastatic castration-resistant prostate cancer (mCRPC)

Creators

• Bracarda, Sergio
• Di Lorenzo, Giuseppe
• Gasparro, Donatello
• Marchetti, Paolo
• BOCCARDO, FRANCESCO
• Martoni, Andrea
• Carteni, Giacomo
• Fornarini, Giuseppe
• Baldazzi, Valentina
• Dogliotti, Luigi
• Messina, Caterina
• Sisani, Michele

Contributors